Everpure, Inc. PSTG
Revenue Intelligence Report • 48 quarters of SEC filing data • Updated 2026-10-14 • Data through 2026-08-02
Everpure, Inc.'s latest quarterly revenue is $1.2B for the period ending 2026-08-02. The model projects $5.2B across the next four quarters (+21.1% versus the preceding four quarters). The forecast uses SG&A data; model selection and estimation exclude the latest quarter, whose retrospective holdout error is 4.6%. These are statistical associations, not estimates of the causal effect of spending.
This page retains the historical ticker PSTG. The SEC now lists Everpure, Inc. under P.
Investment Thesis
The ARDL forecast is based on reported revenue and SG&A data through 2026-08-02. Training MAPE measures fit to historical data; the separately reported holdout error measures a withheld quarter. Spending coefficients describe associations and do not establish causation.
Retrospective one-quarter holdout: model fitting and selection exclude this quarter. Historical inputs use the latest available restatements, so this is not a preserved real-time forecast.
Revenue Forecast
Quarterly Detail
| Quarter | Model Forecast | Actual | 95% Range | YoY Growth | Status |
|---|---|---|---|---|---|
| Q2 FY2027 Period end 2026-08-02 |
$1.13B | $1.19B | $1.01B–$1.27B | +31.3% | ✓ In range |
| Q3 FY2027 Period end 2026-11-02 |
$1.21B | $1.02B–$1.42B | +25.1% | ||
| Q4 FY2027 Period end 2027-02-02 |
$1.19B | $970.9M–$1.45B | +12.0% | ||
| Q1 FY2028 Period end 2027-05-02 |
$1.32B | $1.05B–$1.66B | +25.4% | ||
| Q2 FY2028 Period end 2027-08-02 |
$1.45B | $1.12B–$1.88B | +22.2% |
Seasonal Factors
| Fiscal Quarter | Seasonal Factor | vs Trend | Interpretation | Obs. |
|---|---|---|---|---|
| FQ1 (Feb–Apr) | 0.97 | -3.0% | -3.0% below trend | 10 |
| FQ2 (May–Jul) | 1.0137 | +1.4% | In line with trend | 11 |
| FQ3 (Aug–Oct) | 1.0109 | +1.1% | In line with trend | 11 |
| FQ4 (Nov–Jan) | 1.018 | +1.8% | In line with trend | 11 |
Spending and Revenue
Time-Varying Spending Associations
Current SG&A elasticity: 0.829x • R&D elasticity: 0.5891x
The model-term chart shows relative absolute term magnitudes. Its percentages are not shares of revenue or causal contributions to growth.
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch